NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Fri, 5 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 4, 2024 $62.60 -2.36% $64.96 X 96.36% 0
Oct 4, 2024 Bullish $64.96 V 1
Aug 21, 2024 Bullish $64.76 X 0
Aug 20, 2024 Bullish $66.14 X 0
Aug 20, 2024 $58.40 +2.98% $66.14 V 88.30% 0
Aug 20, 2024 $57.77 +1.86% $66.14 V 87.34% 0
Aug 20, 2024 Bullish $66.14 V 0
Jul 1, 2024 $51.49 -2.87% $55.32 X 93.07% 0
Jul 1, 2024 $52.06 -1.79% $55.32 X 94.10% 0
Jul 1, 2024 Bullish $55.32 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE